BHCM
HCAT icon

Brevan Howard Capital Management’s Health Catalyst HCAT Stock Holding History

Brevan Howard Capital Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-31,633
Closed -$75.6K – 2272
2025
Q4 		$75.6K Buy
+31,633
New +$86.5K ﹤0.01% 1684
2025
Q2 		– Sell
-29,488
Closed -$134K – 1908
2025
Q1 		$134K Buy
29,488
+16,423
+126% +$86.9K ﹤0.01% 1032
2024
Q4 		$92.4K Buy
+13,065
New +$104K ﹤0.01% 970

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brevan Howard Capital Management's HCAT Position: Q1 2026 in Review

Brevan Howard Capital Management sold out of Health Catalyst (HCAT) in Q1 2026, closing a stake of 31,633 shares — an estimated $75.6K sold.

Brevan Howard Capital Management first reported a position in HCAT in Q4 2024 and held it in 3 quarters. The position peaked at $134K in Q1 2025. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Brevan Howard Capital Management reported no remaining Health Catalyst position as of Q1 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 31,633 Health Catalyst shares in Q1 2026, an estimated $75.6K.
  • Brevan Howard Capital Management first reported a position in Health Catalyst in Q4 2024 and held it in 3 quarters.
  • Brevan Howard Capital Management's Health Catalyst position peaked at $134K in Q1 2025.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.